内克塔治疗盘中异动股价大跌5.13%

市场透视2025-05-03

北京时间2025年05月03日03时57分，内克塔治疗（NKTR.us）股票出现异动，股价快速下跌5.13%。截至发稿，该股报0.740美元/股，成交量122.268万股，换手率0.66%，振幅7.04%。最近的财报数据显示，该股实现营业收入98.43百万美元，净利润-1.19亿美元，每股收益-0.58美元，毛利66.47百万美元，市盈率-1.28倍。机构评级方面，在所有8家参与评级的机构中，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2532713538?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-03 03:57","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2532713538","market":"us","top_or_hot":-1,"title":"内克塔治疗盘中异动 股价大跌5.13%","media":"市场透视","content":"<div>\n<p>北京时间2025年05月03日03时57分，内克塔治疗（NKTR.us）股票出现异动，股价快速下跌5.13%。截至发稿，该股报0.740美元/股，成交量122.268万股，换手率0.66%，振幅7.04%。最近的财报数据显示，该股实现营业收入98.43百万美元，净利润-1.19亿美元，每股收益-0.58美元，毛利66.47百万美元，市盈率-1.28倍。机构评级方面，在所有8家参与评级的机构中，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250503035712974d9614&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>内克塔治疗盘中异动 股价大跌5.13%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n内克塔治疗盘中异动 股价大跌5.13%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-03 03:57 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250503035712974d9614&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年05月03日03时57分，内克塔治疗（NKTR.us）股票出现异动，股价快速下跌5.13%。截至发稿，该股报0.740美元/股，成交量122.268万股，换手率0.66%，振幅7.04%。最近的财报数据显示，该股实现营业收入98.43百万美元，净利润-1.19亿美元，每股收益-0.58美元，毛利66.47百万美元，市盈率-1.28倍。机构评级方面，在所有8家参与评级的机构中，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250503035712974d9614&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250503035712974d9614&s=b","article_id":"2532713538","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250503035712974d9614&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2532713538","pubTimestamp":1746215832,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年05月03日03时57分，内克塔治疗股票出现异动，股价快速下跌5.13%。截至发稿，该股报0.740美元/股，成交量122.268万股，换手率0.66%，振幅7.04%。机构评级方面，在所有8家参与评级的机构中，75%的券商给予买入建议，13%的券商给予持有建议，12%的券商给予卖出建议。内克塔治疗股票所在的生物技术行业中，整体涨幅为0.79%。内克塔治疗公司简介：Nektar Therapeutics 是一家制药公司，专注于发现和开发选择性调节免疫系统以治疗自身免疫性疾病的新疗法。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4007":"制药","NKTR":"内克塔治疗"},"translate_title":"Intraday changes in Nekta Therapy's stock price plummeted 5.13%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NKTR":1},"content_text":"北京时间2025年05月03日03时57分，内克塔治疗（NKTR.us）股票出现异动，股价快速下跌5.13%。截至发稿，该股报0.740美元/股，成交量122.268万股，换手率0.66%，振幅7.04%。最近的财报数据显示，该股实现营业收入98.43百万美元，净利润-1.19亿美元，每股收益-0.58美元，毛利66.47百万美元，市盈率-1.28倍。机构评级方面，在所有8家参与评级的机构中，75%的券商给予买入建议，13%的券商给予持有建议，12%的券商给予卖出建议。内克塔治疗股票所在的生物技术行业中，整体涨幅为0.79%。其相关个股中，Polyrizon Ltd.、Celularity Inc C/Wts 16/07/2026 (To Pur Com)、Impact Biomedical, Inc.涨幅较大，Impact Biomedical, Inc.、Pmgc Holdings Inc.、Polyrizon Ltd.较为活跃，换手率分别为1539.90%、848.81%、832.46%，振幅较大的相关个股有Polyrizon Ltd.、Celularity Inc C/Wts 16/07/2026 (To Pur Com)、Impact Biomedical, Inc.，振幅分别为267.88%、175.97%、119.72%。内克塔治疗公司简介：Nektar Therapeutics 是一家制药公司，专注于发现和开发选择性调节免疫系统以治疗自身免疫性疾病的新疗法。该公司专注于发现和开发免疫治疗领域的药物。它的临床阶段和临床前阶段的免疫调节剂针对治疗自身免疫性疾病（例如分别为 rezpegaldesleukin 和 NKTR-0165）和癌症（例如 NKTR-255）。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2532713538","isCrawlerRequest":true}

内克塔治疗盘中异动 股价大跌5.13%

精彩评论

内克塔治疗盘中异动股价大跌5.13%